APA

Jung S. Y., Hwang S., Clarke J. M., Bauer T. M., Keedy V. L., Lee H., Park N., Kim S. & Lee J. I. (20210601). Pharmacokinetic characteristics of vactosertib, a new activin receptor-like kinase 5 inhibitor, in patients with advanced solid tumors in a first-in-human phase 1 study. : Investigational new drugs.

Chicago

Jung Su Young, Hwang Sunjin, Clarke Jeffery M, Bauer Todd M, Keedy Vicki L, Lee Hukeun, Park Neunggyu, Kim Seong-Jin and Lee Jangik I. 20210601. Pharmacokinetic characteristics of vactosertib, a new activin receptor-like kinase 5 inhibitor, in patients with advanced solid tumors in a first-in-human phase 1 study. : Investigational new drugs.

Harvard

Jung S. Y., Hwang S., Clarke J. M., Bauer T. M., Keedy V. L., Lee H., Park N., Kim S. and Lee J. I. (20210601). Pharmacokinetic characteristics of vactosertib, a new activin receptor-like kinase 5 inhibitor, in patients with advanced solid tumors in a first-in-human phase 1 study. : Investigational new drugs.

MLA

Jung Su Young, Hwang Sunjin, Clarke Jeffery M, Bauer Todd M, Keedy Vicki L, Lee Hukeun, Park Neunggyu, Kim Seong-Jin and Lee Jangik I. Pharmacokinetic characteristics of vactosertib, a new activin receptor-like kinase 5 inhibitor, in patients with advanced solid tumors in a first-in-human phase 1 study. : Investigational new drugs. 20210601.